US regulators have relied on flawed and outdated research to allow expanded use of an herbicide linked to cancer, and new assessments should be urgently conducted, according to a column published in the New England Journal of Medicine.
There are two key factors that necessitate regulatory action to protect human health, according to the column: a sharp increase in herbicide applied to widely planted genetically modified (GMO) crops used in food, and a recent World Health Organisation (WHO) determination that the most commonly used herbicide, known as glyphosate, is probably a human carcinogen.